GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 78 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,840 | -69.7% | 2,000 | -50.0% | 0.00% | – |
| Q2 2023 | $12,660 | +29.4% | 4,000 | +100.0% | 0.00% | – |
| Q1 2023 | $9,780 | +69757.1% | 2,000 | -33.3% | 0.00% | – |
| Q4 2022 | $14 | -99.9% | 3,000 | +11.1% | 0.00% | – |
| Q3 2022 | $13,000 | +8.3% | 2,700 | +8.0% | 0.00% | – |
| Q2 2022 | $12,000 | -50.0% | 2,500 | -50.0% | 0.00% | – |
| Q1 2022 | $24,000 | +380.0% | 5,000 | +100.0% | 0.00% | – |
| Q4 2021 | $5,000 | -50.0% | 2,500 | 0.0% | 0.00% | – |
| Q3 2021 | $10,000 | +400.0% | 2,500 | +400.0% | 0.00% | – |
| Q2 2021 | $2,000 | +100.0% | 500 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 500 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | -90.5% | 500 | -88.1% | 0.00% | -100.0% |
| Q1 2019 | $21,000 | -27.6% | 4,200 | -46.2% | 0.00% | +50.0% |
| Q4 2018 | $29,000 | -42.0% | 7,800 | -5.5% | 0.00% | 0.0% |
| Q3 2018 | $50,000 | +47.1% | 8,254 | +55.7% | 0.00% | +100.0% |
| Q2 2018 | $34,000 | +100.0% | 5,300 | +1.9% | 0.00% | 0.0% |
| Q1 2018 | $17,000 | 0.0% | 5,200 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $17,000 | +30.8% | 5,200 | -13.3% | 0.00% | 0.0% |
| Q3 2017 | $13,000 | -13.3% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $15,000 | +7.1% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $14,000 | +133.3% | 6,000 | 0.0% | 0.00% | – |
| Q4 2016 | $6,000 | -25.0% | 6,000 | -14.3% | 0.00% | – |
| Q3 2016 | $8,000 | -20.0% | 7,000 | +4.5% | 0.00% | -100.0% |
| Q2 2016 | $10,000 | -52.4% | 6,700 | +59.5% | 0.00% | -66.7% |
| Q1 2016 | $21,000 | +75.0% | 4,200 | -43.6% | 0.00% | +200.0% |
| Q4 2015 | $12,000 | – | 7,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 169,578 | $222,000 | 0.08% |
| Geneos Wealth Management Inc. | 478,067 | $626,000 | 0.03% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $16,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 281,700 | $369,000 | 0.01% |
| Vivaldi Capital Management LP | 17,078 | $22,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,284,481 | $1,684,000 | 0.00% |
| Ameritas Advisory Services, LLC | 45,302 | $59,000 | 0.00% |
| CENTAURUS FINANCIAL, INC. | 20,947 | $27,000 | 0.00% |
| Summit Trail Advisors, LLC | 23,855 | $31,000 | 0.00% |
| WEDBUSH SECURITIES INC | 27,998 | $37,000 | 0.00% |